In Regulatory or Quality? Leave knowing which of the six constraints still trigger deficiency risk today, and what changed under Section 524B.
In Product Security or Engineering? See where SBOM and vulnerability management are eating the most time — and what's realistic to automate away.
On the leadership side? Get a framework for a portfolio-level risk picture your board will actually accept.
Seth Carmody — who wrote the original 2021 research and spent years as an FDA reviewer — joins Medcrypt CEO Mike Kijewski live, with time for your questions.
Related resources
Go deeper on the topics from this webinar with Medcrypt analysis and real device programs.
Medical device manufacturers (MDMs) are facing a growing push from both regulators and healthcare providers to strengthen the cybersecurity posture of their products. The RunSafe…
Legacy medical devices — those that cannot be reasonably protected against modern cybersecurity threats — pose a serious risk to healthcare institutions. These devices remain in…
